Provided by Tiger Trade Technology Pte. Ltd.

Novus Therapeutics, Inc.

14.60
0.0000
Volume:- -
Turnover:- -
Market Cap:221.34M
PE:-0.65
High:14.60
Open:14.60
Low:14.60
Close:14.60
52wk High:27.32
52wk Low:4.50
Shares:15.16M
Float Shares:8.16M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-22.5110
EPS(LYR):-24.4247
ROE:-21.07%
ROA:-7.29%
PB:10.29
PE(LYR):-0.60

Loading ...

Company Profile

Company Name:
Novus Therapeutics, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Novus Therapeutics, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. Its lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). The company also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. Novus Therapeutics, Inc. is headquartered in Irvine, California.